AvenuesAI Limited’s Board of Directors convened on August 11, 2026, approving key strategic decisions. These include the proposed merger of its wholly-owned subsidiary, Nueromind Technologies Private Limited, the variation of rights issue objects, and the consolidation of equity shares. Additionally, the Board approved an increased investment limit in Ratnaafin Capital Private Limited. The unaudited financial results for the quarter ended June 30, 2026, were also approved.
AvenuesAI Board Approves Strategic Initiatives
On August 11, 2026, the Board of Directors of AvenuesAI Limited (formerly Infibeam Avenues Limited) convened to discuss and approve several pivotal strategic initiatives aimed at streamlining operations and fostering future growth. The Board considered and approved the unaudited financial results for the quarter ended June 30, 2026, alongside a Limited Review Report from the Statutory Auditors.
Merger of Nueromind Technologies
A significant decision was the approval of the draft Scheme of Amalgamation for the merger of Nueromind Technologies Private Limited, a wholly-owned subsidiary, with and into AvenuesAI Limited. This proposed transaction, subject to requisite approvals, aims to consolidate AI capabilities and streamline the group’s structure.
Investment Limit Increase and Rights Issue Variation
The Board re-considered and approved an increase in the investment limit in Ratnaafin Capital Private Limited from Rs. 66.00 Crores to Rs. 70.00 Crores for acquiring not exceeding 2.50% stake. Furthermore, a variation in the objects of the Rights Issue was approved, to directly undertake advanced technology development and AI software-related activities instead of channeling the investment through Nueromind Technologies, which is slated for amalgamation.
Equity Share Consolidation
In a move to rationalize its capital structure, the Board approved the consolidation of 10 (Ten) Equity Shares of Re. 1/- each into 1 (One) Equity Share of Rs. 10/- each, fully paid-up. This action is subject to shareholder and regulatory approvals and aims to align the face value of equity shares with the company’s long-term corporate and strategic objectives.
Convening of Annual General Meeting
The Board also resolved to convene the 16th Annual General Meeting of the Company on Tuesday, September 29, 2026, at 11:00 a.m. IST, to be held through Video Conferencing/Other Audio Visual Means.
Source: BSE
